Biocon Ltd banner

Intrinsic Value

The intrinsic value of Biocon Ltd (532523) under the Base Case is INR per share. Compared with the current market price of 366 INR, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

BIOCON Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Intrinsic value for the past 5 years is hidden
Alert me when BIOCON is below its intrinsic value
Today Hidden ·
Alternatives to BIOCON

Fundamental Analysis

What Biocon Does

Biotechnology Health Care

Biocon Ltd is a biopharmaceutical company that develops and makes medicines for diabetes, cancer, and other long-term illnesses. It sells a mix of biologic drugs, biosimilars, generic formulations, and key ingredients used by other drug makers. The company also works in contract research and development through its services businesses, which support drug discovery and testing for other pharmaceutical firms.

Headquarters
India IN
Employees
16 420
IPO date
Apr 17, 2004
Read the full company overview
View Company Overview

Biocon has a narrow economic moat

No Moat Narrow Wide

Biocon Ltd has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.

Read the full moat analysis
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q2 fiscal 2027 · November 4, 2026

Biocon framed the second half as an execution inflection, with biosimilar momentum, improving generics profitability and a recovering Syngene trajectory supporting commercial acceleration.

Open the earnings call
EPS
₹0.29
Expected
₹1.04
Surprise
−72.1%
Stock, day of the call
+0.4%
View Earnings Call

Past 12 months

Continue BIOCON Research

Decided on Biocon? Get an email when BIOCON reaches the price you’d buy at. Free with an account.

Other Biocon listings

What is the Intrinsic Value of one BIOCON stock?

The intrinsic value for Biocon Ltd (532523) under the Base Case is INR.

Is BIOCON stock undervalued or overvalued?

Compared with the current market price of 366 INR, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top